Delayed reimplantation arthroplasty for candidal prosthetic joint infection: a report of 4 cases and review of the literature.
Fungal prosthetic joint infection (PJI) is rare, with Candida species being the most frequently reported pathogen in the medical literature. The risk of relapse following delayed reimplantation arthroplasty for candidal PJI is unknown. We describe 4 new cases and summarize 6 previously reported cases of candidal PJI treated with delayed reimplantation arthroplasty. Ninety percent of the patients received antifungal therapy. Eight patients received amphotericin B either alone or in combination with other antifungals. One patient received fluconazole alone. The median duration of time from resection arthroplasty to reimplantation for total hip and total knee arthroplasties was 8.6 and 2.3 months, respectively. Eight patients did not have relapse of candidal PJI following delayed reimplantation arthroplasty after a median duration of follow-up of 50.7 months (range, 2--73 months). Candidal PJI can be successfully treated with delayed reimplantation arthroplasty after receipt appropriate antifungal therapy.
Phelan
David M
DM
Division of Infectious Diseases, Department of Internal Medicine, Mayo Clinic and Foundation, Rochester, MN, 55905, USA.
Osmon
Douglas R
DR
Keating
Michael R
MR
Hanssen
Arlen D
AD
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001178:Arthroplasty / Q000009:adverse effects*; D002177:Candidiasis / Q000453:epidemiology* / Q000209:etiology / Q000382:microbiology / Q000628:therapy; D005260:Female; D006801:Humans; D007592:Joint Diseases / Q000453:epidemiology* / Q000209:etiology / Q000382:microbiology / Q000628:therapy; D008297:Male; D008875:Middle Aged; D016459:Prosthesis-Related Infections / Q000453:epidemiology* / Q000209:etiology / Q000382:microbiology / Q000628:therapy; D012092:Replantation; D012189:Retrospective Studies; D016896:Treatment Outcome